Back to Agenda
Session 5. Clinical Research Regulations : Critical Aspects that Impacts Clinical Research Practices
Session Chair(s)
Ellyne Setiawan, MPharm
Head of Research & Development Quality (Asia Pacific),, Daiichi Sankyo Singapore Pte. Ltd., Singapore
Senthil Sockalingam
Head of Medical Affairs, APAC, BeiGene, Singapore
Speaker(s)
Peter Twomey, MA, MPharm
Head of Inspections, European Medicines Agency, Netherlands
Overview of ICH GCP E6 (R3) Renovation
Cathy Dove
Director Quality & Risk Management, DQS, United Kingdom
ICH E6 R3 DCT – A Clinical Trial Odyssey
Sandy Chan
Associate Director, Regulatory Policy & Intelligence Lead- Asia Pacific, Johnson & Johnson, Singapore
Regulatory Landscape of Decentralised Clinical Trials in Asia Pacific
Rosemarie Corrigan
Executive Vice President, Global Quality Worldwide Clinical Trials, United Kingdom
Xing Li, MSc
CEO & CSO, Deep Intelligent Pharma ( Singapore) private limited, Singapore
Sharon Chen
Founder and CEO, AlphaLife Sciences, United States
Have an account?